Signify Health, Inc. (NYSE:SGFY) Receives Consensus “Buy Moderate” Rating from Brokers
Signify Health, Inc. (NYSE:SGFY – Get Rating) received an average “moderate buy” recommendation from the nine brokerages that currently cover the business, Marketbeat Ratings reports. One research analyst rated the stock with a hold rating and seven gave the company a buy rating. The 12-month average price target among brokerages that updated their coverage on the stock in the past year is $26.33.
Several equity research analysts have recently released reports on the stock. Robert W. Baird upgraded Signify Health shares from a ‘neutral’ rating to an ‘outperforming’ rating and lowered the stock’s target price from $19.00 to $16.00 in a research note Monday, May 16. Deutsche Bank Aktiengesellschaft lowered its price target on Signify Health shares from $29.00 to $26.00 in a Friday, May 6 research note. Guggenheim kicked off Signify Health stock coverage in a Tuesday, March 29 research report. They set a “buy” rating and a price target of $36.00 for the company. Piper Sandler raised her price target on Signify Health shares from $27.00 to $32.00 and gave the stock an “overweight” rating in a Monday, June 6 research report. Finally, Goldman Sachs Group raised its price target on Signify Health shares from $20.00 to $22.00 and gave the stock a “buy” rating in a Monday, March 21 research report.
NYSE: SGFY opened at $15.35 on Friday. The company’s fifty-day moving average is $13.42 and its two-hundred-day moving average is $14.19. The company has a debt ratio of 0.22, a quick ratio of 4.82 and a current ratio of 4.82. Signify Health has a one-year minimum of $10.70 and a one-year maximum of $30.96. The company has a market capitalization of $3.59 billion, a price/earnings ratio of 80.79, a PEG ratio of 2.50 and a beta of 1.55.
Signify Health (NYSE:SGFY – Get Rating) last released its results on Wednesday, May 4. The company reported earnings per share (EPS) of $0.11 for the quarter, beating the consensus estimate of $0.03 by $0.08. Signify Health had a net margin of 3.95% and a return on equity of 3.22%. The company posted revenue of $216.50 million for the quarter, versus analyst estimates of $213.21 million. During the same period of the previous year, the company posted EPS of $0.20. The company’s revenue for the quarter increased 20.3% on an annual basis. As a group, equity research analysts expect Signify Health to post 0.13 earnings per share for the current fiscal year.
In other news from Signify Health, Bradford CEO Kyle Armbrester acquired 8,320 shares of the company in a transaction on Monday, May 9. The stock was purchased at an average price of $11.77 per share, for a total transaction of $97,926.40. Following the acquisition, the CEO now owns 92,693 shares of the company, valued at $1,090,996.61. The purchase was disclosed in a filing with the Securities & Exchange Commission, accessible via this link. Additionally, insider Steve Senneff acquired 10,000 shares of the company in a trade on Friday, May 6. The shares were acquired at an average price of $12.55 per share, with a total value of $125,500.00. Following the acquisition, the insider now owns 215,087 shares of the company, valued at approximately $2,699,341.85. Disclosure of this purchase can be found here. During the last quarter, insiders acquired 20,820 shares of the company valued at $252,801. 8.02% of the shares are held by insiders.
Several hedge funds and other institutional investors have recently changed their positions in the company. Bank of America Corp DE increased its equity stake in Signify Health by 117.6% in Q1. Bank of America Corp DE now owns 484,140 shares of the company worth $8,787,000 after buying an additional 261,623 shares in the last quarter. Walleye Capital LLC acquired a new stake in shares of Signify Health during Q1 worth approximately $414,000. Portolan Capital Management LLC acquired a new stake in the shares of Signify Health during Q1 for a value of approximately $6,129,000. Quantamental Technologies LLC acquired a new stake in shares of Signify Health during Q1 worth approximately $185,000. Finally, Guggenheim Capital LLC increased its stake in Signify Health shares by 0.9% during the 1st quarter. Guggenheim Capital LLC now owns 228,986 shares of the company worth $4,156,000 after purchasing an additional 1,990 shares in the last quarter.
Company Profile Signify Health (Get an assessment)
Signify Health, Inc operates a healthcare platform that uses analytics, technology and healthcare provider networks in the United States. The Company operates through Home & Community Services and Episodes of Care Services segments. The Home & Community Services segment offers health assessments performed in the patient’s home or at a health care facility primarily to Medicare Advantage health plans; diagnostic screening and other ancillary services; and services to address health concerns related to the social determinants of health.
Get news and reviews for Signify Health Daily – Enter your email address below to receive a concise daily summary of the latest news and analyst ratings for Signify Health and related companies with MarketBeat.com’s free daily email newsletter.